Antibody estimation methods

Direct two-step and one-step immunoassays estimate free hormone concentrations by using antibody extraction techniques. Although it is often clauned or implied that these immunoextraction assays measure FT or FT3 directly, virtually all methods do so indirectly by relating test results to extracted serum calibrators with free hormone values that have been independently measured using reference methods (e.g.,. direct equilibrium dialysis/RlA). Further, studies have shown that all of the free hormone estimate methods on current instrument platforms are binding protein dependent to some extent. ... 

To guide model development, the observed data were first examined graphically to determine general characteristics and to look for trends with respect to dose, time, and the impact of anti-mAb antibodies. Models were developed using NONMEM (Version 5). Two different model types were developed the first model (MODEL 1, see Appendix 45.1) used an analytical solution (closed-form) where the nonlinearity was accounted for by allowing the model parameters to be a function of mAb dose and the titer of anti-mAb antibody, while the second model (MODEL 2, see Appendix 45.2) used differential equations to allow a more mechanistic approach to characterize the nonlinearity. For each model, three estimation methods were evaluated first-order (FO), first-order conditional estimation (FOCE), and FOCE with interaction. Various forms of between-subject variability models were evalu-... 

Alternatively, competitive ELISA can be used to estimate the hapten density if an antibody that specitically recognizes the hapten is available. At first observation this approach seems circular because the immunoassay developed is used to determine hapten density on proteins used for immunization. However, if a small molecule mimic of the protein conjugate is used as a standard, the method can be accurate. For example, a hapten containing a carboxylic acid can be coupled to phenethylamine or tyramine, its structure confirmed and the material used to generate a calibratron curve to estimate hapten density. 

RIA for hydromorphone and hydrocodone are fairly sensitive in the nanogram per millilitre range but essentially require the preparation of a specific antibody. The laid-out RIA method is quite capable of estimating the above drugs within a range of 2.5-20 ng ml 1 using standard 100 pi plasma sample only. 

Once transfectomas have been generated, they must be screened for the production of the desired fusion. The binding site provided by the expression of the VNP heavy chain in J558L cells and association of the heavy chain with the resident light chain means that the protein fusion can be captured on a solid phase by NP or NIP, and detected using commercially available antibody to mouse X chain and an appropriate enzyme conjugate, in a simple ELISA screening procedure. Similarly, purification can be achieved by affinity adsorption of the fusion onto an NP matrix. An immunoblot method is described here for characterization of selected transfectomas, which allows the mol-wt of the fusion product to be estimated. 

Preparation of Insulins. Until the early 1980s insulin for therapeutic purposes was produced almost exclusively by extraction from beef and pork pancreases. Between 100 and 400 mg of insulin can be obtained from each kg of pancreatic tissue, and it has been estimated that there would be sufficient supplies of animal insulin to meet the requirements of diabetic patients into the twenty-first century (2). Through modem purification procedures animal insulins can be prepared in essentially pure form, which eliminates the possibility of developing antibodies against impurities in the insulin preparations. However, patients treated with purified insulins still develop antibodies to insulin, suggesting that differences in the primary structures of these insulins might stimulate antibody production. Therefore, enzymatic and biosynthetic methods have been developed for the preparation of therapeutic insulin identical to human insulin. 

According to Ekins [27], the fundamental difference between competitive and non-competitive methods is based solely on the approach adopted to detect the antibody occupancy from which the analyte concentration in the system is deduced. Competitive assays rely on the indirect measurement of occupancy by observation of unoccupied sites. In this case the amount of antibody must be kept small to minimize errors in the indirect estimate of the occupied sites. Non-competitive assays rely on direct measurement of binding site occupancy so that the use of large amounts of antibody is advantageous. 

The development of immunoassays for the detection of food components and contaminants has progressed rapidly in the last few years [7]. Antibodies against almost all the important food residues compounds are currently available. Classical immunochemical methods such as immunodiffusion and agglutination methods for food analyses generally involve no labeled antigen or antibody. Concentration of the antigen-antibody complex is estimated from the secondary reaction that leads to precipitation or agglutination. These methods are not sensitive, are subject to... 

The diligent analyst would develop a robust method with rigorous matrix effect tests on multiple lots, including hemolyzed and lipidemic samples. An initial test would be a spike-recovery evaluation on at least six individual lots. Samples should be spiked at or near the LLOQ, and at a high level near the ULOQ. If matrix interference were indicated by unacceptable relative error (RE) percentage in certain lots, the spiked sample of the unacceptable lots should be diluted with the standard calibrator matrix to estimate the minimum dilution requirement (MDR) at and above which the spike-recovery is acceptable. The spike-recovery test should then be repeated with the test samples diluted at the MDR. Note that this approach will increase the LLOQ for a less sensitive assay. If sensitivity is an issue, then other venues will be required to address the matrix effect problem. For example, the method can be modified to include sample clean-up, antibodies and/or assay conditions may be changed, or the study purpose may be tolerable to acknowledge that the method may not be selective for a few patients (whose data may require special interpretation). 

The objective of the experiments is to compare the affinity of wild-type antibody and wild-type immunogen (chicken lysozyme) with that of wild-type antibody and mutant antigen or with that of mutant antibody and wild-type immunogen. All the assays involve incubation of a constant concentration of one reactant with varying amounts of the complementary reactant, along with estimating the concentration of either bound or free reactant by an immunochemical or enzymatic method. In each case, the assumption is made that the measurement step does not disturb the equilibrium between antigen and antibody, and it is important that this assumption be validated experimentally. We summarize below several alternative methods. 

Also, HPLC methods with electrochemical or fluorescent detection are used (H19, M3). In proteins, dityrosine can be estimated by immunochemical methods employing dityrosine-specific antibodies (K5). Measurements of o,o -dityrosine and o-tyrosine levels in rat urine express dityrosine contents in skeletal muscle proteins, and have been proposed as the noninvasive oxidative stress test in vivo. One should be aware, however, that A-formylkynurenine, also formed in protein oxidation, has similar fluorescence properties as dityrosine (excitation 325 nm, emission at 400-450 nm) (G29). Also, oxidation of mellitin when excited at 325 nm produces an increase in fluorescence at 400—450 nm, despite the fact that mellitin does not contain tyrosine. Oxidation of noncontaining Trp residues ribonuclease A and bovine pancreatic trypsin inhibitor with "OH produces loss of tyrosine residues with no increase in fluorescence at 410 nm (S51). There are also methods measuring the increased hydrophobicity of oxidized proteins. Assays are carried out measuring protein binding of a fluorescent probe, 8-anilino-l-naphthalene-sulfonic acid (ANS). Increase in probe binding reflects increased surface hydrophobicity (C7). 

---